OptimizeRx/OPRX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About OptimizeRx

OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.

Ticker

OPRX

Sector

Technology

Trading on

NASDAQ

Industry

Advertising

CEO

William Febbo

Employees

116

Headquarters

Waltham, United States

OptimizeRx Metrics

BasicAdvanced
$220M
Market cap
-
P/E ratio
-$1.03
EPS
1.28
Beta
-
Dividend rate
$220M
1.27803
$16.65
$6.92
155K
2.884
26.451
29.308
-10.66%
-11.73%
-14.66%
-12.74%
2.817
1.789
26.71%
-28.66%
18.20%

What the Analysts think about OptimizeRx

Analyst Ratings

Majority rating from 7 analysts.
Buy

OptimizeRx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-34.69% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$20M
-30.74%
Net income
-$6.8M
65.85%
Profit margin
-34.69%
139.57%

OptimizeRx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 13.73%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.01
$0.09
$0.26
-$0.11
-
Expected
-$0.02
$0.03
$0.32
-$0.13
-$0.05
Surprise
-53.33%
260.00%
-19.50%
-13.73%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for OptimizeRx stock?

OptimizeRx (OPRX) has a market cap of $220M as of June 18, 2024.

What is the P/E ratio for OptimizeRx stock?

The price to earnings (P/E) ratio for OptimizeRx (OPRX) stock is 0 as of June 18, 2024.

Does OptimizeRx stock pay dividends?

No, OptimizeRx (OPRX) stock does not pay dividends to its shareholders as of June 18, 2024.

When is the next OptimizeRx dividend payment date?

OptimizeRx (OPRX) stock does not pay dividends to its shareholders.

What is the beta indicator for OptimizeRx?

OptimizeRx (OPRX) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell OptimizeRx stock

Buy or sell OptimizeRx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing